Newsroom
Strive to Deliver Breakthroughs
Cambridge, MA, Rotterdam, NL, Shanghai, CN — April 10, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to th...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — March 31, 2025 Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a glob...
View moreShanghai, CN, Cambridge, MA, Rotterdam, NL – March 21, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company ...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN – March 12, 2025 - Élancé Therapeutics aims to improve current obesi...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — March 10, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to th...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — March 10, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to th...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN – February 25, 2025 HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company inc...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — February 20, 2025 Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceut...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN – February 13, 2025 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceu...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — February 4, 2025 Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceuti...
View more